Combination of Osimertinib with Durvalumab in Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer: Is There Room for Reinvestigation?

  • Ahn, Myung-Ju
Citations

WEB OF SCIENCE

13
Citations

SCOPUS

12

키워드

IMMUNE ESCAPE; EGFR; ACTIVATION; PD-L1
제목
Combination of Osimertinib with Durvalumab in Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer: Is There Room for Reinvestigation?
저자
Ahn, Myung-Ju
DOI
10.1016/j.jtho.2019.03.005
발행일
2019-05
유형
Editorial Material
저널명
Journal of Thoracic Oncology
권
14
호
5
페이지
766 ~ 767